chr17-63971859-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_000334.4(SCN4A):c.483-9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000229 in 1,503,966 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00016 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00024 ( 3 hom. )
Consequence
SCN4A
NM_000334.4 intron
NM_000334.4 intron
Scores
2
Splicing: ADA: 0.000008939
2
Clinical Significance
Conservation
PhyloP100: -0.152
Publications
0 publications found
Genes affected
SCN4A (HGNC:10591): (sodium voltage-gated channel alpha subunit 4) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. It is expressed in skeletal muscle, and mutations in this gene have been linked to several myotonia and periodic paralysis disorders. [provided by RefSeq, Jul 2008]
SCN4A Gene-Disease associations (from GenCC):
- hyperkalemic periodic paralysisInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Orphanet
- paramyotonia congenita of Von EulenburgInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Orphanet
- SCN4A-related myopathy, autosomal recessiveInheritance: AR Classification: DEFINITIVE Submitted by: Illumina, ClinGen
- hypokalemic periodic paralysis, type 2Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- potassium-aggravated myotoniaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- congenital myasthenic syndrome 16Inheritance: AR Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- congenital myopathyInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- congenital myopathy 22A, classicInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- acetazolamide-responsive myotoniaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hypokalemic periodic paralysisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myotonia fluctuansInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myotonia permanensInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 17-63971859-G-A is Benign according to our data. Variant chr17-63971859-G-A is described in ClinVar as Benign. ClinVar VariationId is 758817.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000158 (19/120524) while in subpopulation SAS AF = 0.00516 (19/3682). AF 95% confidence interval is 0.00338. There are 0 homozygotes in GnomAd4. There are 15 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR,AD gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 19AN: 120402Hom.: 0 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
19
AN:
120402
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000483 AC: 115AN: 238328 AF XY: 0.000656 show subpopulations
GnomAD2 exomes
AF:
AC:
115
AN:
238328
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000236 AC: 326AN: 1383442Hom.: 3 Cov.: 33 AF XY: 0.000336 AC XY: 230AN XY: 684624 show subpopulations
GnomAD4 exome
AF:
AC:
326
AN:
1383442
Hom.:
Cov.:
33
AF XY:
AC XY:
230
AN XY:
684624
show subpopulations
African (AFR)
AF:
AC:
1
AN:
31718
American (AMR)
AF:
AC:
0
AN:
40576
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
24598
East Asian (EAS)
AF:
AC:
1
AN:
36974
South Asian (SAS)
AF:
AC:
316
AN:
69960
European-Finnish (FIN)
AF:
AC:
0
AN:
49318
Middle Eastern (MID)
AF:
AC:
1
AN:
5506
European-Non Finnish (NFE)
AF:
AC:
1
AN:
1068368
Other (OTH)
AF:
AC:
6
AN:
56424
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
18
36
55
73
91
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000158 AC: 19AN: 120524Hom.: 0 Cov.: 30 AF XY: 0.000252 AC XY: 15AN XY: 59608 show subpopulations
GnomAD4 genome
AF:
AC:
19
AN:
120524
Hom.:
Cov.:
30
AF XY:
AC XY:
15
AN XY:
59608
show subpopulations
African (AFR)
AF:
AC:
0
AN:
32114
American (AMR)
AF:
AC:
0
AN:
12026
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2722
East Asian (EAS)
AF:
AC:
0
AN:
4254
South Asian (SAS)
AF:
AC:
19
AN:
3682
European-Finnish (FIN)
AF:
AC:
0
AN:
9420
Middle Eastern (MID)
AF:
AC:
0
AN:
214
European-Non Finnish (NFE)
AF:
AC:
0
AN:
53784
Other (OTH)
AF:
AC:
0
AN:
1562
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.528
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Familial hyperkalemic periodic paralysis Benign:1
Oct 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.